Think you know who this headline refers to? Actually, it’s Dr José Baselga whose extensive corporate relationships – and his frequent failure to disclose them – illustrate how permeable the boundaries remain between academic research and industry, and how weakly reporting requirements are enforced by the medical journals and professional societies charged with policing them. Now think who this applies to in the UK addiction prescribing field…


